RS Research raised €11M in a Series A round in Dec 2021. The company is based in Istanbul, Türkiye. Investors in the round: Eczacıbaşı Momentum, GEN İlaç, GEN Pharmaceuticals and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
